Nipro KK

8086

Equity

ISIN JP3673600007 / Valor 763952

Tokyo Stock Exchange (2024-09-17)

JPY 1,342.50+0.90%

Nipro KK
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Nipro KK, established in 1954, is a diversified global healthcare company that plays a significant role in the pharmaceutical and medical device industries. It specializes in the manufacture of a wide range of products, including pharmaceutical packaging solutions, renal care products, and medical devices for interventional cardiology. Nipro PharmaPackaging offers an extensive array of packaging options, from glass tubing to finished products, tailored to meet the stringent requirements of the pharmaceutical sector. In the realm of cardiology, Nipro has made strides with its intravascular imaging technology, focusing on the diagnosis and management of coronary artery disease, building upon the foundational research of Infraredx, a Nipro subsidiary. The company is also a recognized leader in renal care, providing comprehensive solutions for hemodialysis and dialysis-related treatments, emphasizing innovation and patient safety. Additionally, Nipro manufactures environmental disinfection equipment, such as the CLFine system, which uses ionless hypochlorous water to sanitize air and surfaces, and is one of the world's largest producers of needles, offering products for injection, infusion, and blood collection. Its Surefuser™+ device is designed for the safe administration of chemotherapy treatments, showcasing Nipro's commitment to enhancing patient care across various medical fields.

Summarized from source with an LLMView SourceSector: Healthcare

Net Sales

Nipro KK reported net sales of 586,785 million yen for the fourth quarter of the fiscal year 2024. This represents an increase from the previous year's net sales of 545,199 million yen, indicating a positive growth trend in the company's revenue.

Operating Income

For the fourth quarter of the fiscal year 2024, Nipro KK's operating income was 22,335 million yen, with an operating income ratio of 3.8%. This is an improvement from the previous year's operating income of 17,729 million yen and an operating income ratio of 3.3%.

Ordinary Income

Nipro KK's ordinary income for the fourth quarter of the fiscal year 2024 was 19,509 million yen, with an ordinary income ratio of 3.3%. This shows an increase compared to the previous year's ordinary income of 15,346 million yen and an ordinary income ratio of 2.8%.

Net Income

The net income for Nipro KK in the fourth quarter of the fiscal year 2024 was 11,109 million yen, with a net income ratio of 1.9%. This is a significant rise from the previous year's net income of 4,574 million yen and a net income ratio of 0.8%.

Dividends

Nipro KK declared cash dividends per share of 25.0 yen for the fourth quarter of the fiscal year 2024. This is an increase from the previous year's dividends of 22.0 yen per share, reflecting the company's commitment to returning value to its shareholders.

Summarized from source with an LLMView Source

Key figures

8.70%1Y

12.3%3Y

7.83%5Y

Performance

24.9%1Y

21.1%3Y

23.5%5Y

Volatility